[作为全血或血液成分的自体输血?]

V Kretschmer, M Weippert-Kretschmer
{"title":"[作为全血或血液成分的自体输血?]","authors":"V Kretschmer,&nbsp;M Weippert-Kretschmer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Modern haemotherapy is equivalent to restrictive use of blood components. Therefore, transfusion of whole blood in homologous transfusion generally cannot be accepted. In autologous blood transfusion blood components also are preferable if they can be separated appropriately. In order to have broad application of preoperative autologous blood deposits, close cooperation to transfusion services should be established guaranteeing optimal production of blood components. If this cooperation is impossible there are no objections against the use of autologous whole blood as long as the expected blood consumption is less than 3 red cell units. Additionally, in this case storage of more than 3 weeks mostly is not necessary. The fact that whole blood is not further part of the 'Monographien' of the Federal Health Administration (BGA) does not forbid the use of autologous whole blood since the 'Monographien' only concern generally available homologous blood components.</p>","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"31 ","pages":"209-14"},"PeriodicalIF":0.0000,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Autologous blood transfusion as whole blood or blood components?].\",\"authors\":\"V Kretschmer,&nbsp;M Weippert-Kretschmer\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Modern haemotherapy is equivalent to restrictive use of blood components. Therefore, transfusion of whole blood in homologous transfusion generally cannot be accepted. In autologous blood transfusion blood components also are preferable if they can be separated appropriately. In order to have broad application of preoperative autologous blood deposits, close cooperation to transfusion services should be established guaranteeing optimal production of blood components. If this cooperation is impossible there are no objections against the use of autologous whole blood as long as the expected blood consumption is less than 3 red cell units. Additionally, in this case storage of more than 3 weeks mostly is not necessary. The fact that whole blood is not further part of the 'Monographien' of the Federal Health Administration (BGA) does not forbid the use of autologous whole blood since the 'Monographien' only concern generally available homologous blood components.</p>\",\"PeriodicalId\":77034,\"journal\":{\"name\":\"Beitrage zur Infusionstherapie = Contributions to infusion therapy\",\"volume\":\"31 \",\"pages\":\"209-14\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1993-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Beitrage zur Infusionstherapie = Contributions to infusion therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

现代血液疗法相当于限制使用血液成分。因此,在同型输血中,一般不能接受全血输注。在自体输血中,如果能适当地分离血液成分,也是可取的。为了使术前自体血液储备得到广泛应用,应与输血服务部门密切合作,保证血液成分的最佳生产。如果这种合作是不可能的,也没有反对使用自体全血,只要预期血液消耗少于3个红细胞单位。此外,在这种情况下,储存超过3周大多是没有必要的。全血不是联邦卫生管理局(BGA)“专论”的进一步组成部分,这一事实并不禁止使用自体全血,因为“专论”只涉及普遍可用的同源血液成分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Autologous blood transfusion as whole blood or blood components?].

Modern haemotherapy is equivalent to restrictive use of blood components. Therefore, transfusion of whole blood in homologous transfusion generally cannot be accepted. In autologous blood transfusion blood components also are preferable if they can be separated appropriately. In order to have broad application of preoperative autologous blood deposits, close cooperation to transfusion services should be established guaranteeing optimal production of blood components. If this cooperation is impossible there are no objections against the use of autologous whole blood as long as the expected blood consumption is less than 3 red cell units. Additionally, in this case storage of more than 3 weeks mostly is not necessary. The fact that whole blood is not further part of the 'Monographien' of the Federal Health Administration (BGA) does not forbid the use of autologous whole blood since the 'Monographien' only concern generally available homologous blood components.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Magnesium Infusion Therapy Opioid Infusion Therapy Dexmedetomidine Infusion Therapy Clonidine Infusion Therapy Lidocaine Infusion Therapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1